Prominent cancer researchers are using the ThunderBolts™ Cancer Panel together with the RainDrop™ Digital PCR System to research, validate and monitor common cancer mutations in primary tumors. During the recent AACR Annual Meeting, several First Access Participants presented their findings demonstrating the high sensitivity, low starting sample requirements and simple workflow in breast, colorectal, esophageal, and pancreatic cancer studies.
- Andrew Brooks, Ph.D., Chief Operating Officer, RUCDR Infinite Biologics
- Tony Godfrey, Ph.D., Associate Chair for Surgical Research and Associate Professor of Surgery at Boston University School of Medicine
- Andrew Rhim, M.D., Assistant Professor of Internal Medicine and Assistant Director for Translational Research, University of Michigan Medical School
- Fraser Symmans, M.D., Director of Research Operations, MD Anderson Cancer Center
Want more information?
Get in touch with our team to learn more about ThunderBolts™ Cancer Panel.